Financing through the issuance of the 4th series of stock acquisition rights by third-party allotment
First written in FY2018. 3 of 5 entries say "Advanced", first in FY2019-Q2. Latest entry: FY2020-Q3.
1 other company's latest entry also says "Advanced".
- FY2020-Q3AdvancedAnnual report
「1 May 2020–31 July 2020 80,000,000 299,333,169 25,000 987,878 25,000 537,878 (Note) This increase was due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in an increase of 80,000,000 common shares between 1 May and 31 July 2020, while capital stock and the capital reserve each increased by ¥25 million. - FY2020-Q2AdvancedAnnual report
「Change in total number of issued shares (shares): 25,000,000. (Note) This increase was due to the exercise of stock acquisition rights.」
Between 1 February and 30 April 2020, 25,000,000 shares were issued through the exercise of the fourth series of stock acquisition rights. - FY2019-Q2AdvancedAnnual report
「The fourth series of stock acquisition rights held by EVO FUND were exercised on 13 May 2019. The details of the exercise were as follows: (1) Class and number of shares issued: 116,000,000 common shares; (2) total issue proceeds: ¥232 million.」
116,000,000 shares underlying the fourth series of stock acquisition rights were issued on 13 May 2019, raising ¥232 million. - FY2019-Q1RestatedAnnual report
「Number of stock acquisition rights (units) * 2,210,000 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares) * Common shares 221,000,000 (Note 1) Exercise period of the stock acquisition rights * 13 November 2018–13 November 2023」
The company continued to disclose 2,210,000 units of the fourth series of stock acquisition rights, 221,000,000 underlying shares and an exercise period from 13 November 2018 to 13 November 2023. - FY2018First statedAnnual report
「Accordingly, to resolve this situation, at a meeting of its board of directors held on 20 September 2018, the company resolved to submit a proposal for the issuance of the fourth series of stock acquisition rights by way of a third-party allotment to the extraordinary general meeting of shareholders to be held on 9 November 2018. After putting itself in a position to raise funds, the company plans to continue discussions and negotiations with the creditor in question.」
To address interest-bearing liabilities for which the company had lost the benefit of time and to continue negotiations with creditors, the company resolved to issue the fourth series of stock acquisition rights by way of a third-party allotment and stated for the first time its policy of putting itself in a position to raise funds. The disclosure states that there were 2,210,000 stock acquisition rights, 221,000,000 underlying shares and an exercise period from 13 November 2018 to 13 November 2023.